Calcineurin inhibitor (immunosuppressant)PopPK (2-compartment)IV continuous infusionHematology / Transplantation

Tacrolimus pop pk model

Indication: Pediatric/young adult hematopoietic cell transplantation

Population pharmacokinetic simulator for tacrolimus IV continuous infusion in pediatric and young adult patients undergoing hematopoietic cell transplantation (HCT). Two-compartment model with allometric weight scaling and CYP3A4/5 inhibitor effect. Based on Brooks et al. (2021).

Drug Overview

Clinical Context

Molecular Target
Calcineurin
Drug Class
Calcineurin inhibitor (immunosuppressant)
Therapeutic Area
Hematology / Transplantation
Indication
Pediatric/young adult hematopoietic cell transplantation
Route of Administration
IV continuous infusion

Model Information

Model Type
PopPK (2-compartment)
Reference
Brooks et al. (2021) Front Pharmacol

This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.

Pharmacokinetic Parameters

PK Parameters

ParameterValue
Qintercompartmental clearance (allometric)
CLallometric weight-scaled
V1central volume (allometric)
V2peripheral volume (allometric)

Parameters sourced from published population pharmacokinetic models. Values represent typical population estimates; individual patient parameters may vary.

About This Simulator

This interactive pharmacokinetic simulator for Tacrolimus pop allows you to explore concentration-time profiles under different dosing scenarios. The underlying PopPK (2-compartment) model characterizes the pharmacokinetics of this calcineurin inhibitor (immunosuppressant) following iv continuous infusion administration.

Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).

Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.

Frequently Asked Questions

What is the Tacrolimus pop PK simulator?

This is a free, interactive pharmacokinetic simulator for Tacrolimus pop used in Pediatric/young adult hematopoietic cell transplantation. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.

What drug class does Tacrolimus pop belong to?

Tacrolimus pop is classified as a Calcineurin inhibitor (immunosuppressant) that targets Calcineurin. It is used in the Hematology / Transplantation therapeutic area.

What route of administration does this model simulate?

This simulator models IV continuous infusion administration of Tacrolimus pop. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.

What type of PK model is used?

This simulator uses a PopPK (2-compartment) model. Population PK models account for interindividual variability and covariate effects on drug exposure.

Is this simulator free to use?

Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.

Can I use this for clinical dosing decisions?

No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.

What is the clearance of Tacrolimus pop?

The clearance (CL) of Tacrolimus pop is approximately allometric weight-scaled. Clearance represents the volume of plasma from which drug is completely removed per unit time and is a key determinant of drug exposure and steady-state concentrations.

Ready to Simulate?

Launch the Tacrolimus pop simulator to explore dosing scenarios and pharmacokinetic profiles interactively.

🚀 Launch Simulator

Comments

0/2000
Loading comments...

⚠️ Disclaimer

This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.

Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community